David Minarik
11 – 20 of 43
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Auto-segmentations by convolutional neural network in cervical and anorectal cancer with clinical structure sets as the ground truth
(
- Contribution to journal › Article
- 2019
-
Mark
Impact of penalizing factor in a block-sequential regularized expectation maximization reconstruction algorithm for
18
F-fluorocholine PET-CT regarding image quality and interpretation
(
- Contribution to journal › Article
-
Mark
Comparison of conventional and Si-photomultiplier-based PET systems for image quality and diagnostic performance
(
- Contribution to journal › Article
-
Mark
Impact of acquisition time and penalizing factor in a block-sequential regularized expectation maximization reconstruction algorithm on a Si-photomultiplier-based PET-CT system for 18F-FDG
(
- Contribution to journal › Article
-
Mark
The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations
(
- Contribution to journal › Article
-
Mark
Measurement of airway inflammation in current smokers by positron emission tomography
(
- Contribution to journal › Article
- 2018
-
Mark
Evaluation of changes in Bone Scan Index at different acquisition time-points in bone scintigraphy
(
- Contribution to journal › Article
- 2017
-
Mark
Reply: A Common Mistake in Assessing the Diagnostic Value of a Test: Failure to Account for Statistical and Methodologic Issues
(
- Contribution to journal › Letter
- 2016
-
Mark
Analytical Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize the Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide.
(
- Contribution to journal › Article